Table 2. Correlations between miRNA-143 expression and clinico-pathological parameters.
|
miRNA-143 expression
|
|||
|---|---|---|---|
| Clinico-pathological parameter | miRNA-143 low ( n =41) | miRNA-143 high ( n =36) | P -value |
| Age (years) | |||
| <60 | 17 (40.4%) | 18 (50%) | 0.453 |
| ⩾60 | 24 (59.6%) | 18 (50%) | |
| Gender | |||
| Male | 30 (73.2%) | 22 (61.1%) | 0.259 |
| Female | 11 (26.8%) | 14 (38.9%) | |
| Tumour location | |||
| Colon | 25 (61%) | 24 (66.7%) | 0.604 |
| Rectum | 16 (39%) | 12 (33.3%) | |
| Tumour grade | |||
| G1 | 1 (2.4%) | 1 (2.8%) | 0.495 |
| G2 | 28 (68.3%) | 27 (75%) | |
| G3 | 12 (29.3%) | 8 (22.2%) | |
| Stage | |||
| II–III | 14 (34.1%) | 18 (50%) | 0.137 |
| IV | 27 (65.9%) | 18 (50%) | |
| Levels of tumour marker (median ng ml−1) | |||
| CEA | 4 | 3 | 0.606 |
Abbreviations: CEA=carcinoembryonic antigen; miRNA=microRNA.